Ardelyx (ARDX) Change in Acquisitions & Divestments (2017 - 2026)
Ardelyx (ARDX) reported Change in Acquisitions & Divestments of $37.9 million for Q1 2026, up 9.28% on a YoY basis from $34.7 million in Q1 2025, and down 31.0% quarter-over-quarter from $55.0 million in Q4 2025.
Ardelyx (ARDX) Change in Acquisitions & Divestments (2017 - 2026) Analysis & Trends
Ardelyx has reported Change in Acquisitions & Divestments for 10 years, with the latest figure at $37.9 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Acquisitions & Divestments rose 9.28% year-over-year to $37.9 million; the trailing twelve-month figure through Mar 2026 stood at $214.7 million (up 18.62% YoY), and the FY2025 full-year result was $211.5 million, up 18.89% from the prior year.
- Change in Acquisitions & Divestments for Q1 2026 stood at $37.9 million, down from $55.0 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $63.3 million in Q3 2025, with the low at $8.0 million in Q4 2022.
- Historically, Change in Acquisitions & Divestments has averaged $34.0 million across 5 years, with a median of $34.7 million in 2025.
- Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments tumbled 63.64% — and 2023, when it jumped 500.71%.
- Ardelyx's Change in Acquisitions & Divestments stood at $8.0 million in 2022, then jumped by 500.71% to $48.1 million in 2023, then advanced by 19.65% to $57.5 million in 2024, then fell by 4.35% to $55.0 million in 2025, then slumped by 31.0% to $37.9 million in 2026.
- The last three Change in Acquisitions & Divestments figures came in at $37.9 million (Q1 2026), $55.0 million (Q4 2025), and $63.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.95 Mn |
| Mar 31, 2026 | 37.95 Mn |
| Dec 31, 2025 | 55.00 Mn |
| Dec 31, 2025 | 55.00 Mn |
| Sep 30, 2025 | 63.35 Mn |
| Sep 30, 2025 | 63.35 Mn |
| Jun 30, 2025 | 58.38 Mn |
| Jun 30, 2025 | 58.38 Mn |
| Mar 31, 2025 | 34.73 Mn |
| Mar 31, 2025 | 34.73 Mn |
| Dec 31, 2024 | 57.50 Mn |
| Dec 31, 2024 | 57.50 Mn |
| Sep 30, 2024 | 42.24 Mn |
| Sep 30, 2024 | 42.24 Mn |
| Jun 30, 2024 | 46.51 Mn |
| Jun 30, 2024 | 46.51 Mn |
| Mar 31, 2024 | 31.60 Mn |
| Mar 31, 2024 | 31.60 Mn |
| Dec 31, 2023 | 48.06 Mn |
| Dec 31, 2023 | 48.06 Mn |